JENNIFER REYNALDO: Open Payments
NPI 1891779468 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 57 payments from 10 companies in 2025. Trend: 2023 $914 · 2024 $797 · 2025 $1,250
Food & beverage: $1,185Education: $65
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $322 |
| ABBVIE INC. | 17 | $293 |
| Novo Nordisk Inc | 9 | $211 |
| PFIZER INC. | 8 | $168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $76 |
| Lilly USA, LLC | 4 | $75 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| Endo USA, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: AIRSUPRA, UBRELVY, NURTEC ODT, VRAYLAR, FARXIGA, XIFAXAN, Ozempic, MOUNJARO.
Industry payments across VA — which companies pay providers there.
